Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with a breast cancer diagnosis who are initiating therapy on palbociclib (Ibrance)
\>/= 18 years of age
Able to speak, read and write English
Willingness and ability to send and receive text messages with intervention app
Own a mobile telephone "smartphone" with text messaging capabilities. Only iPhone or Android operating systems support OhMD Application
Criteria applicable for both Control and Intervention groups
Flip-phones do not support OhMD Application and thus ineligible to participate
Initiation palbociclib (Ibrance) for the first time, either as monotherapy or in conjunction with other medication such as Lstrozole (Femara) or Fulvestrant (Faslodex)
You may not be if
History of taking palbociclib (Ibrance)
Patients whose caregivers coordinate their health care
Clareo Health | A Study of the Use of Text Message Reminders to Take Palbociclib
